Loading
Semnur Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Denali Capital Global Investments LLC, was filed 13 Apr 2022.
Semnur Pharmaceuticals, Inc.: what insiders have been doing
Semnur Pharmaceuticals, Inc. belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Semnur Pharmaceuticals, Inc. in twelve months, the latest record being from 25 September 2025.
Over the whole record (from 2022), the tally stands at 1 purchase and 2 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
4
Thresholds
n/a
Buy Volume
€5M
1 ops. · all time
Sell Volume
€169M
2 ops. · all time
Who traded when
BuySaleScilex Holding Co2 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.40
Analyst consensus
Income statement
EBITDA-US$160.4M
Net income-US$160.4M0.0% margin
Valuation
Beta-0.03
Balance sheet & cash
Market capUS$92.1M
Total debtUS$15.4M
Free Cash Flow-US$5.9M
Profitability & ownership
ROA-1900.2%
% insiders84.3%
% institutions0.0%
Last declaration on 25 September 2025
Declarations4 total
554,849 shares@ US$16.00Common StockSEC:0001193125-25-218151:1
11,945,151 shares@ US$16.00100.0% of flowCommon StockSEC:0001193125-25-218151:0
510,000 shares@ US$10.00100.0% of flowClass A Ordinary SharesSEC:0001140361-22-014407:0
Canonical exit: 10 Jul 2022 (T+90)
▲
Same trade as the filing by Denali Capital Global Investments LLC, counted once
5M USD22SEC
510,000 shares@ US$10.00100.0% of flowClass A Ordinary SharesSEC:0001140361-22-014405:0
Canonical exit: 10 Jul 2022 (T+90)
4 of 4 declarations
About Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. is a company focused on developing treatments for pain and neurological disorders. It is listed on NASDAQ under the ticker XNAS.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
